Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Yuyan
MRDinS3LC, NCT06081777: Significance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung Cancer	Recruiting	N/A	65	RoW		Peking University Cancer Hospital & Institute, Geneplus-Beijing Co. Ltd.	NSCLC	06/25	06/25
Jia, Bo
MRDinS3LC, NCT06081777: Significance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung Cancer	Recruiting	N/A	65	RoW		Peking University Cancer Hospital & Institute, Geneplus-Beijing Co. Ltd.	NSCLC	06/25	06/25